Dec 2022: Atezolizumab (Tecentriq, Genentech, Inc.) waxaa ansixisay Maamulka Cuntada iyo Dawooyinka (FDA) ee loogu talagalay bukaanada qaangaarka ah iyo carruurta ee leh qaybta jilicsan ee alveolar ee aan la soo saari karin ama metastatic sarcoma kuwaas oo ah 2 sano
Dis 2021: Daawooyinka soo socda ayaa la ansixiyay laga bilaabo taariikhda daawaynta kansarka beerka:. Fadlan hubi macluumaadka laguu qoray ka hor inta aanad dawada qaadan. Atezolizumab Avastin (Bevacizumab) Bevacizumab Cabometyx (Cabozantinib-SM)
Noofambar 2021: Maamulka Cuntada iyo Dawooyinka ayaa ansixiyay atezolizumab (Tecentriq, Genentech, Inc.) ee daawaynta adjuvant ee bukaanada leh marxaladda II ilaa IIIA kansarka sambabada unugyada aan-yare ahayn (NSCLC) kuwaas oo burooyinkooda ay ka kooban yihiin PD-L1 o.